Showing results (1661-1670 of 1,763) with videos related to
Sort By:
Pageof 177
JAMA Network Open|June 28, 2023
Enhancing Partnerships of Institutions and Journals to Address Concerns About Research Misconduct: Recommendations From a Working Group of Institutional Research Integrity Officers and Journal Editors and PublishersSusan Garfinkel, Sabina Alam, Patricia Baskin, et al.The Lancet. Haematology|August 28, 2020
Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trialDonald M Arnold, Nancy M Heddle, Richard J Cook, et al.Journal of Medicinal Chemistry|December 7, 2017
A Dipolar Cycloaddition Reaction To Access 6-Methyl-4,5,6,7-tetrahydro-1H-[1,2,3]triazolo[4,5-c]pyridines Enables the Discovery Synthesis and Preclinical Profiling of a P2X7 Antagonist Clinical CandidateChrista C Chrovian, Akinola Soyode-Johnson, Alexander A Peterson, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|March 22, 2021
Cervical cord myelin abnormality is associated with clinical disability in multiple sclerosisLisa Eunyoung Lee, Irene M Vavasour, Adam Dvorak, et al.The Lancet. Psychiatry|March 20, 2022
Combined social communication therapy at home and in education for young autistic children in England (PACT-G): a parallel, single-blind, randomised controlled trialJonathan Green, Kathy Leadbitter, Ceri Ellis, et al.Nature Communications|August 29, 2023
Neonatal and maternal outcomes following SARS-CoV-2 infection and COVID-19 vaccination: a population-based matched cohort studyLaura Lindsay, Clara Calvert, Ting Shi, et al.Journal of Medicinal Chemistry|September 5, 2003
The first potent and selective non-imidazole human histamine H4 receptor antagonistsJill A Jablonowski, Cheryl A Grice, Wenying Chai, et al.Blood Advances|December 31, 2021
T-replete HLA-matched grafts vs T-depleted HLA-mismatched grafts in inborn errors of immunitySu Han Lum, Sinéad Greener, Inigo Perez-Heras, et al.Journal of Medicinal Chemistry|August 23, 2016
Identification of (R)-(2-Chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyridin-2-yl)-4-methyl-6,7-dihydro-1H-imidazo[4,5-c]pyridin-5(4H)-yl)methanone (JNJ 54166060), a Small Molecule Antagonist of the P2X7 receptorDevin M Swanson, Brad M Savall, Kevin J Coe, et al.Science Translational Medicine|December 14, 2018
A point-of-care diagnostic for differentiating Ebola from endemic febrile diseasesDavid Sebba, Alexander G Lastovich, Melody Kuroda, et al.Pageof 177